23andMe files for bankruptcy, customers advised to delete DNA data

23andMe has filed for Chapter 11 and plans to sell its assets, prompting privacy concerns that customer genetic data could be exposed during a sale; regulators and privacy experts urge customers to delete data and revoke consents. The report also summarizes a confirmed 2023 breach where attackers exfiltrated health reports and raw genotype data from about 6.4 million customers via credential-stuffing, leading to lawsuits and a $30M settlement, and notes ongoing regulatory scrutiny under GDPR and consumer protection authorities.